Last updated: May 24, 2026
Modern cardiology practices implant devices from multiple manufacturers. Each OEM, including Medtronic, Boston Scientific, Abbott, and Biotronik, operates a separate, non-interoperable remote monitoring portal. Staff must log into each portal independently, reconcile conflicting data formats, and manually transcribe findings into the EHR. This fragmentation drives alert fatigue, billing errors, and staff burnout.
EHR vendors such as Epic, Oracle Health (Cerner), and Athenahealth have accelerated cloud adoption by publishing integration frameworks, including Epic's App Orchard and Cerner's CODE program, that reward platforms capable of bi-directional data exchange. Bi-directional EHR integration for CIED platforms requires confirming EHR endpoints, aligning on patient ID strategy, mapping discrete data fields, and establishing encounter and billing logic. On-premise systems like PaceArt Optima were never architected to perform this work at scale.
On the billing side, CMS remote monitoring CPT codes (93298, 93299, 99454) require documented transmission counts, clinician review timestamps, and frequency-rule compliance. Manual workflows built around PaceArt Optima routinely miss these documentation thresholds, which leaves revenue uncaptured. Cloud platforms that automate CPT documentation at the point of data ingestion close this gap structurally rather than procedurally. With these ecosystem challenges in mind, the following comparison shows how PaceMateLIVE and Rhythm360 address the pain points described above.
The table below compares PaceMateLIVE and Rhythm360 across the criteria most consequential to a PaceArt Optima migration. Where published data is unavailable for a specific vendor, the cell is noted accordingly.
| Criterion | PaceArt Optima (Legacy Baseline) | PaceMateLIVE | Rhythm360 |
|---|---|---|---|
| Historical data migration | On-premise, structured device records, session logs, patient notes | Migration scope defined by PaceMate onboarding, post-acquisition support commitments per 2024 acquisition terms | Ingests historical PDFs via computer vision/OCR plus structured data, >99.9% transmissibility via redundant data feeds |
| EHR integration (bi-directional) | None native, manual export and import | Integration capabilities per PaceMate documentation (not independently verified) | Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health via HL7, EHR integration for CIED platforms can often be completed within a few weeks |
| Per-patient monthly cost | On-premise licensing, no per-patient cloud fee | Not publicly disclosed | SaaS model scaled by clinic size and usage, off-the-shelf RPM platforms at mid-scale run $40–$75 per patient per month |
| CPT automation (93298/99454) | Manual documentation required | Billing automation per PaceMate product claims | Automated CPT capture, audit-ready documentation, frequency-rule compliance built into workflow, cloud platforms replacing Paceart-class systems report improved billing accuracy and faster reimbursement cycles |
| AI alert triage | None, manual review | Alert management per PaceMate product claims | AI-powered triage reduces critical alert response times by up to 80%, optional 24/7/365 CCT oversight |
| Data portability / exit clause | Data held on-premise, practice owns hardware | Contractual terms not publicly disclosed | Vendor-neutral, practice retains data ownership, no OEM affiliation creates exit flexibility |
Practices evaluating total cost of ownership should note that off-the-shelf RPM platform costs scale with patient volume. Teams should weigh these costs against CPT revenue recovered through automation and staff hours recaptured from manual workflows.
Vendor lock-in vs. data ownership. Migrating to a platform with OEM affiliation, or one that does not contractually guarantee data portability, recreates the same exit risk that the PaceArt acquisition exposed. Vendor-neutral platforms with explicit data-ownership clauses provide structural protection against future acquisition-driven disruptions.
Implementation timeline vs. clinical disruption. EHR integrations for CIED platforms in well-configured environments can complete in under a day, while complex enterprise environments may require several additional weeks. Practices should negotiate a parallel-run period, maintaining PaceArt Optima access while the new platform is validated, to prevent alert coverage gaps.
In-house CCTs vs. 24/7 oversight. Practices relying solely on in-house staff for alert triage face coverage gaps on nights, weekends, and holidays. Platforms offering optional 24/7/365 oversight by IBHRE-certified cardiac technicians provide a clinical safety net without requiring additional FTE hiring.
Common pitfalls to avoid:
Clinical: Target an 80% reduction in critical alert response times post-migration. Track missed-event rate, defined as unreviewed transmissions older than 24 hours, as a primary patient safety KPI. Monitor AFib, VT, and device malfunction detection latency against pre-migration baselines.
Operational: Measure staff hours per 100 transmissions before and after migration. A unified dashboard that eliminates multi-portal logins should produce measurable reductions in administrative time within 60 days of go-live.
Financial: Track net new CPT revenue captured per month for codes 93298, 93299, and 99454, along with claim acceptance rate and days-to-reimbursement. Practices implementing automated CPT workflows have reported revenue increases of up to 300% over manual baseline processes.
Compliance: Confirm >99.9% data transmissibility at 90 days post-migration. Verify zero HIPAA audit findings related to PHI transport, access logging, or BAA coverage gaps. Retain post-migration audit documentation as evidence of due diligence.
Historical PaceArt Optima records exist in two forms: structured database records, including device parameters, session logs, and patient demographics, and unstructured PDF reports, including signed physician documents and transmission summaries. Structured records can typically be exported and mapped to a cloud platform's data schema. Unstructured PDFs require a platform with optical character recognition or computer vision capabilities to parse and index the content. Without this capability, legacy PDF reports become inaccessible after migration.
Practices should explicitly confirm with any prospective platform vendor which data element types are migrated, how completeness is validated, and what the retention policy is for records that cannot be parsed. Rhythm360 uses AI-powered computer vision to ingest both structured and unstructured historical data, which preserves clinical continuity across the migration boundary.
EHR integration timelines for CIED platforms vary by EHR system, clinic IT resources, and the complexity of the existing configuration. In well-configured ambulatory environments, integrations can complete in under a day. In large enterprise systems such as Epic or Oracle Health, previously Cerner, the process typically spans several weeks and involves multi-stakeholder coordination among hospital IT, EHR analysts, security teams, and the platform vendor.
The process includes phases such as discovery and scoping, connectivity and field mapping, and validation, training, and go-live. The most common delays involve patient ID matching across MRN, NPI, payer IDs, and device serial numbers, along with encounter and billing logic configuration. Rhythm360's onboarding process, including EHR integration, is designed to complete within a few days to a few weeks depending on environment complexity.
As noted in the comparison section, per-patient costs for off-the-shelf remote cardiac monitoring platforms at mid-scale volumes often run $40–$75 per patient per month. Total platform costs scale with patient volume. These figures exclude device hardware kits, which typically cost $50–$200 per patient for initial setup, and cellular connectivity fees, which often range from $5–$15 per patient per month.
Total cost of ownership evaluations should offset platform costs against CPT revenue recovered through automated billing workflows, which can increase practice profitability by as much as 300% compared to manual PaceArt Optima-era processes. Rhythm360 uses a SaaS pricing model scaled to clinic size and platform usage, which provides cost flexibility as patient volumes grow.
PaceArt Optima relies on manual review workflows with no native AI triage layer. Clinicians must log into the system, retrieve transmissions, and prioritize alerts without algorithmic support, which creates alert fatigue and delays response to critical events such as new-onset AFib, ventricular tachycardia, or device malfunction. Cloud platforms with AI-powered alert triage filter non-actionable transmissions and surface clinically significant events in priority order.
The 80% response-time improvement cited in the success metrics section is typically measurable within the first 30–60 days post-migration, particularly for weekend and after-hours coverage where manual processes are most vulnerable. Rhythm360's AI triage system supports this improvement by standardizing prioritization and reducing manual sorting time.
PaceMate's August 2024 acquisition of Medtronic’s Paceart Optima system, which was rebranded as PaceArt, converted a previously stable on-premise workflow into an active migration decision. Practices that evaluate this transition solely on feature parity risk underweighting the criteria that most directly affect long-term operational independence, including data portability, exit clause terms, vendor neutrality, and CPT automation depth.
PaceMateLIVE represents a direct migration path within the PaceMate ecosystem. Vendor-neutral platforms like Rhythm360 offer an alternative that eliminates OEM affiliation, consolidates all manufacturer data into a single dashboard, automates CPT documentation, and provides bi-directional EHR integration with Epic, Cerner, Athenahealth, and others. The implementation timeline is typically measured in days to weeks rather than months.
The seven-step checklist and comparison framework in this guide provide a structured basis for evaluating both options against your practice's specific data scope, billing volume, clinical staffing model, and contractual risk tolerance. The migration decision made now will define your platform dependency and your exit options for the next several years.
